Top compounds associated with response to EIF2D


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.00016 1
mRNA HG-6-64-1 GDSC1000 pan-cancer AAC -0.00015 1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.00013 1
mRNA VX-680 CTRPv2 pan-cancer AAC 0.00032 1
mRNA GDC-0449 GDSC1000 pan-cancer AAC -7.4e-05 1
mRNA GSK269962A GDSC1000 pan-cancer AAC 3.3e-05 1
Download CSV